Literature DB >> 26547267

Linagliptin-Role in the Reversal of Aβ-Mediated Impairment of Insulin Signaling and Reduced Neurotoxicity in AD Pathogenesis: Some Considerations.

Nuggehally R Srinivas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26547267      PMCID： PMC6493141          DOI： 10.1111/cns.12475

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN： 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  2 in total

1.  Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent.

Authors:  Bassam M Ayoub; Shereen Mowaka; Marwa M Safar; Nermeen Ashoush; Mona G Arafa; Haidy E Michel; Mariam M Tadros; Mohamed M Elmazar; Shaker A Mousa
Journal:  Sci Rep       Date:  2018-06-12       Impact factor: 4.379

Review 2.  Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents.

Authors:  Shaker A Mousa; Bassam M Ayoub
Journal:  Neural Regen Res       Date:  2019-05       Impact factor: 5.135
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.